Responding to the Clopidogrel Warning by the US Food and Drug Administration: Real Life Is Complicated

Circulation - United States
doi 10.1161/circulationaha.110.973362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

Transparency and Dermatologic Device Approval by the US Food and Drug Administration

JAMA Dermatology
DermatologyMedicine
2018English

Is the Food and Drug Administration Safe and Effective?

Journal of Economic Perspectives
EconomicsEconometrics
2008English

The Clinical Pharmacogeneticist: An Emerging Regulatory Scientist at the US Food and Drug Administration

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2010English

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2018English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1986English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1993English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1991English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy